The global Pharma Contract Research Organization (CRO) services market is experiencing significant growth, projected to reach USD 87.03 billion by 2034, up from USD 36.66 billion in 2025, reflecting a CAGR of 10.04% over the forecast period. North America led the market in 2024, while the Asia-Pacific region is anticipated to exhibit the fastest growth during the forecast period. In terms of service offerings, discovery services dominated in 2024, with preclinical services expected to grow at the fastest rate. Oncology remained the leading therapeutic area, with cardiovascular disorders anticipated to witness significant growth in the coming years.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5567
Top 10 Contract Research Organizations (CROs) leading the industry:
1. IQVIA
Headquarters: Durham, North Carolina, USA
2023 Revenue: USD 14.98 billion
Services: Clinical trials, real-world evidence, data analytics, regulatory consulting
Strengths: Extensive global presence, advanced analytics capabilities, strong client base in biopharma
Recent Developments: Reported strong Q2 2025 earnings, indicating a rebound in biotech and pharma spending
2. ICON plc
Headquarters: Dublin, Ireland
2023 Revenue: USD 3.7 billion
Services: Full-service clinical development, commercialization, regulatory affairs
Strengths: Specialized in oncology, immuno-oncology, and cell and gene therapies
Recent Developments: Participated in over 760 oncology studies globally
3. PPD (Pharmaceutical Product Development)
Headquarters: Wilmington, North Carolina, USA
2023 Revenue: USD 2.3 billion
Services: Clinical trials, laboratory services, patient and investigator recruitment
Strengths: Strong presence in early-phase research and laboratory services
Recent Developments: Reported strong Q2 2025 earnings, signaling stabilization in biotech and pharma spending
4. Medpace
Headquarters: Cincinnati, Ohio, USA
2023 Revenue: USD 2.2 billion
Services: Full-service clinical trials, regulatory affairs, data management
Strengths: Rapid growth, strong client relationships, expertise in oncology and rare diseases
Recent Developments: Raised full-year revenue guidance due to improved funding conditions and accelerated client decisions
5. Parexel
Headquarters: Durham, North Carolina, USA
2023 Revenue: USD 2.5 billion
Services: Clinical trials, regulatory consulting, market access
Strengths: Strong regulatory expertise, global reach, diverse therapeutic area coverage
Recent Developments: Expanded capabilities in cell and gene therapy trials
6. Labcorp Drug Development
Headquarters: Burlington, North Carolina, USA
2023 Revenue: USD 6.3 billion
Services: Clinical trials, laboratory services, commercialization
Strengths: Integrated services from discovery to commercialization, strong laboratory capabilities
Recent Developments: Enhanced focus on precision medicine and biomarker-driven trials
7. Syneos Health
Headquarters: Morrisville, North Carolina, USA
2023 Revenue: USD 2.5 billion
Services: Clinical trials, commercialization, patient recruitment
Strengths: Strong focus on patient-centric trials, integrated solutions
Recent Developments: Expanded global footprint and capabilities in rare disease trials
8. Charles River Laboratories
Headquarters: Wilmington, Massachusetts, USA
2023 Revenue: USD 3.2 billion
Services: Preclinical services, clinical trials, laboratory services
Strengths: Expertise in early-phase research, strong laboratory capabilities
Recent Developments: Expanded services in gene therapy and cell therapy research
9. Covance (A Labcorp Company)
Headquarters: Madison, Wisconsin, USA
2023 Revenue: USD 1.8 billion
Services: Clinical trials, laboratory services, commercialization
Strengths: Integrated services, strong laboratory capabilities
Recent Developments: Enhanced focus on precision medicine and biomarker-driven trials
10. WuXi AppTec
Headquarters: Shanghai, China
2023 Revenue: USD 3.5 billion
Services: Preclinical services, clinical trials, manufacturing
Strengths: Comprehensive services from discovery to commercialization, strong presence in Asia
Recent Developments: Expanded capabilities in cell and gene therapy research
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5567
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About the Author
